No drug has yet been approved to treat hearing loss, and alternative strategies such as cochlear implants only partly restore hearing function. Now, two papers from researchers at Harvard Medical School report the ability of a synthetic adeno-associated virus (AAV) vector to efficiently deliver a

中文翻译：

---

听力损失：载体克服了基因疗法交付的障碍

尚未批准用于治疗听力损失的药物，替代方法（例如人工耳蜗）只能部分恢复听力功能。现在，哈佛医学院的研究人员发表的两篇论文报告了合成腺相关病毒（AAV）载体有效递送腺相关病毒的能力。